Every executive departure read straight from the 8-K, filtered to the company size you serve, the morning it lands.See it live →
Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as Chief Financial Officer
RECENTLY ACQUIREDSep 15, 2026•1 day ago
Position
Chief Medical Officer
Company
Serapha Bio
Hat YaiBiotechnologyHealth CareTherapeuticsDescription
Serapha Bio, Inc. announces the appointment of Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as President and Chief Financial Officer among other key executive roles
Don't miss Serapha Bio's next move
Get an email the moment Serapha Bio changes its leadership, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Executive Insights
Based on hiring dataNew executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months
Serapha Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.